The following is a list of selected recently published Expert Opinion articles, related to the content of this issue of Expert Opinion on Investigational Drugs
Inhibitory effects of isoliquiritigenin on the migration and invasion of human breast cancer cell Kai-Lee Wang, Shih-Min Hsia, Chia-Jung Chan, Full-Young Chang, Chih-Yang Huang, Da-Tian Bau & Paulus S Wang Posted online on January 18, 2013 (doi:10.1517/14728222.2013.756869)
Aflibercept in lung cancer Joel W Neal & Heather A Wakelee January 2013, Vol. 13, No. 1, Pages 115-120 (doi:10.1517/14712598.2013.745847)
Ligand-based receptor tyrosine kinase partial agonists: new paradigm for cancer drug discovery? David J Riese II, George Fulton Gilliland & Olga Hooser Gilliland Franklin February 2011, Vol. 6, No. 2, Pages 185-193 (doi:10.1517/17460441.2011.547468)
Selective cannabinoid receptor 2 modulators: a patent review 2009 – present Doris Riether May 2012, Vol. 22, No. 5, Pages 495-510 (doi:10.1517/13543776.2012.682570)
Emerging drugs for functional dyspepsia Jan Tack & Pieter Janssen June 2011, Vol. 16, No. 2, Pages 283-292 (doi:10.1517/14728214.2011.558502)
Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation Serap Gur, Philip J Kadowitz & Wayne JG Hellstrom January 2013, Vol. 12, No. 1, Pages 81-90 (doi:10.1517/14740338.2013.742885)
Establishing the clinical and economic benefits of adherence to 5-alpha reductase inhibitors in benign prostatic hyperplasia: an assessment of Medicare and Medicaid patients Michael Eaddy, Eric Kruep, Orsolya Lunacsek & Bridget Goodwin December 2012, Vol. 13, No. 18, Pages 2593-2600 (doi:10.1517/14656566.2012.744821)
Silodosin: a new subtype selective alpha-1 antagonist for the treatment of lower urinary tract symptoms in patients with benign prostatic hyperplasia Nadir I Osman, Christopher R Chapple, Francisco Cruz, François Desgrandchamps, Carlos Llorente & Francesco Montorsi October 2012, Vol. 13, No. 14, Pages 2085-2096 (doi:10.1517/14656566.2012.714368)
Emerging drugs for the treatment of benign prostatic obstruction Hashim Hashim MD FRCS FEBU Urology Specialist Registrar & Paul Abrams June 2010, Vol. 15, No. 2, Pages 159-174 (doi:10.1517/14728211003716459)
Inhibitory effects of isoliquiritigenin on the migration and invasion of human breast cancer cells Kai-Lee Wang, Shih-Min Hsia, Chia-Jung Chan, Full-Young Chang, Chih-Yang Huang, Da-Tian Bau & Paulus S Wang Posted online on January 18, 2013 (doi:10.1517/14728222.2013.756869)